Literature DB >> 17196862

Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.

Caterina Aurizi1, Xiaoye Schneider-Yin, Fiammetta Sorge, Annelisa Macrì, Elisabeth I Minder, Gianfranco Biolcati.   

Abstract

Mutations and a low-expressed allele IVS3-48c (in trans to the mutation) of the ferrochelatase (FECH) gene are responsible for erythropoietic protoporphyria (EPP) which is characterized clinically by cutaneous photosensitivity. In this study of 15 Italian EPP families, we identified 10 different FECH gene mutations, six of them were novel mutations (Q32X; IVS2-2, a-->g; IVS3-67, g-->a; 488-501del 14bp; IVS5-3, c-->t and 757-761delAGAAG). Four were known mutations (213insT; R115X; S264L and 899-900delTG). Real-time PCR quantification of FECH mRNA from a patient carrying mutation IVS-67, g-->a revealed a 51% reduction in the normal FECH transcript. This mutation generated an abnormal mRNA species with a 63-bp intron 3 retention--the same mRNA species which the low-expressed FECH allele IVS3-48c also produces. In addition, a double intronic deletion (IVS8-61 del ag /IVS9-58 del a) was found in some patients as well as their healthy relatives of this cohort. Sequencing of 50 Italian control subjects revealed an 11% prevalence of the double deletion. However, the double intronic deletion is not a disease-causing mutation as evidenced by a normal amount of FECH mRNA measured from a non-porphyric individual who carried the double deletion. Another interesting finding of this study was a 1% prevalence of IVS3-48c allele in the white Italian population, comparing to 11% in the French population. Further epidemiological studies are needed to test whether the 1% frequency of the low-expressed IVS3-48c allele is associated with a low prevalence of EPP in the white Italian population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196862     DOI: 10.1016/j.ymgme.2006.10.012

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  4 in total

1.  Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.

Authors:  Victoria E Parera; Rita H Koole; Gardi Minderman; Annie Edixhoven; Maria V Rossetti; Alcira Batlle; Felix W M de Rooij
Journal:  Mol Med       Date:  2009-08-12       Impact factor: 6.354

2.  Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family.

Authors:  X Schneider-Yin; R Mamet; E I Minder; N Schoenfeld
Journal:  J Inherit Metab Dis       Date:  2008-08-31       Impact factor: 4.982

Review 3.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123

4.  A framework for application of metabolic modeling in yeast to predict the effects of nsSNV in human orthologs.

Authors:  Hayley Dingerdissen; Daniel S Weaver; Peter D Karp; Yang Pan; Vahan Simonyan; Raja Mazumder
Journal:  Biol Direct       Date:  2014-06-03       Impact factor: 4.540

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.